Related Experiment Videos
[Treatment for Kawasaki disease--perspective]
Hiromichi Hamada1, Masaru Terai
1Department of Pediatrics, Tokyo Women's Medical University Yachiyo Medical Center.
Insights
Kawasaki disease management is evolving. New treatments like corticosteroids and TNF-alpha blockade are explored for non-responders, while therapeutic angiogenesis shows promise for long-term coronary artery issues.
Area of Science:
- Pediatric rheumatology and cardiology
- Immunology and inflammation research
- Vascular biology and regenerative medicine
Context:
- Kawasaki disease (KD) is a leading cause of acquired pediatric heart disease.
- Current acute management relies on intravenous gamma globulin (IVGG) and aspirin.
- Refractory cases and long-term sequelae present significant clinical challenges.
Purpose:
- To review current and emerging therapeutic strategies for Kawasaki disease.
- To explore novel treatments for acute non-responders.
- To discuss the potential of therapeutic angiogenesis for long-term cardiovascular complications.
Summary:
- Acute management research focuses on adjunctive therapies for IVGG-refractory patients, including corticosteroids and TNF-alpha inhibitors.
- Long-term management strategies are exploring therapeutic angiogenesis, a technique currently used for adult ischemic conditions.
- This approach may offer future treatment options for pediatric patients with KD-associated coronary artery abnormalities.
Impact:
- Potential for improved outcomes in acute Kawasaki disease management.
- New avenues for preventing or treating coronary artery aneurysms and stenosis in KD survivors.
- Advancement of regenerative medicine principles in pediatric cardiovascular disease.
Abstract:
In acute management for Kawasaki disease, recent studies are focused on treatment for patients who failed to respond to intravenous gamma globulin (IVGG) and high dose-aspirin. The addition of corticosteroids to IVGG and the use of TNF-alpha blockade are now under discussion. In long-term management, therapeutic angiogenesis is now applied for adult patients with ischemic hind limb or heart. It could be one of the therapeutic options for children and adolescents with Kawasaki disease and coronary artery abnormalities.
Related Concept Videos
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease IV: Nursing Management
Pericarditis III: Medical Management
Myocarditis III: Medical Management
Pericarditis IV: Nursing Management
Endocarditis III: Medical Management